<DOC>
	<DOCNO>NCT01378741</DOCNO>
	<brief_summary>The objective study reduce incidence postoperative delirium cardiac surgery elderly patient . This proposal clinical trial design reduce delirium patient undergoing cardiac surgery replace standard postoperative sedation protocol ( propofol , midazolam , opioids ) new alpha2-adrenergic receptor agonist ( dexmedetomidine ) possess sedative , analgesic , antinociceptive property . Resource utilization analysis perform determine cost effectiveness new treatment modality .</brief_summary>
	<brief_title>Reducing Delirium After Cardiac Surgery : A Multifaceted Approach Of Perioperative Care</brief_title>
	<detailed_description>The propose study prospective , randomize , open label study compare multimodal protocol postoperative sedation cardiac surgery . Patients randomly allocate either dexmedetomidine propofol ( control ) group accord computer generate randomization code predetermine size block four .</detailed_description>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Age â‰¥60 year , undergo high risk cardiac surgery , sign informed consent . Patients symptomatic cerebrovascular disease , history delirium , schizophrenia preoperative use psychotropic medication .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>delirium</keyword>
	<keyword>cardiac surgery</keyword>
	<keyword>postoperative sedation</keyword>
</DOC>